Update to CRUK Consent Forms

The CRUK SACT regimen-specific consent form project team is pleased to announce that a number of consent forms have been updated and published. They are now available on the CRUK website at: www.cruk.org/sact_consent.

CLL
New forms added for zanubrutinib and ibrutinib plus venetoclax.

Generic SACT and immunotherapy consent forms
These are the first forms published on the new consent form template.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Best Wishes,
Lucy

Lucy Cox
Cancer Research UK Specialist Pharmacist – Cancer Information Lead

Latest News

By BOPA Executive Committee on 16th June 2026

BOPA Fellowship Nominations 2026 are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing…

Read article
By Pharmaceutical Press (PhP) on 15th June 2026

Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest: We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP). PhP is developing a new resource to support healthcare…

Read article
By BOPA Research Subcommittee on 15th June 2026

Deadline EXTENDED: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   Deadline for Abstract Submission for the 29th Annual BOPA Conference 2026 has been EXTENDED! Don’t miss the…

Read article
By BOPA on 15th June 2026

The BOPA Training and Development Grant – BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article